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Abstract
Background: The rising incidence of diabetes within the United States and worldwide has led to
increased diabetes related morbidity and mortality. As the leading cause of end stage renal
disease (ESRD), more attention needs to be placed on increasing rates of diabetic nephropathy
screening. The vast majority of diabetics are treated in primary care, positioning primary care as
a center focus for diabetes related screening and treatment.
Local problem: Low rates of diabetic nephropathy screening were noted at an academic medical
center affiliated primary care clinic. A quality improvement initiative was elicited to increase
the number of urine microalbumin creatine ratio tests ordered by primary care providers.
Methods: Using the Plan-Do-Study-Act (PDSA) framework, a pre-visit planning intervention
aimed at reducing missed opportunities during primary care visits was enacted over a 2 month
period. The specific aim of this quality improvement initiative was to increase the number of
ordered uACR screening tests in patients with type 1 and type 2 between the ages 18 and 75 who
had not had a test completed within the past year.
Interventions: A report was generated the day prior to scheduled visit encounters for those
diabetic patients overdue for a diabetic nephropathy screening. uACR orders were queued and
pended for provider signature within the upcoming visit encounter. The pending order flagged
the medical assistant (MA) to prepare a specimen cup. The provider handed the patient the
specimen cup at the conclusion of the visit for the urine to be collected.
Results: Of the 91 diabetic patients seen during the intervention, 87 patients had an order for a
uACR signed during the visit encounter. This demonstrates an order compliance rate of 95.6%,
an improvement by 26.7 percentage points when compared to the to the preintervention data.
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Conclusions: This quality improvement initiative underscored the importance of avoiding
missed opportunities and taking advantage of all patient contact to perform diabetes follow up as
a team. The increased number of signed uACR orders during the intervention brings to light the
potential advantages of a pre-charting to avoid missing vital recommended screening tests.

Keywords: Diabetic nephropathy, urine albumin creatinine ratio, diabetic kidney disease,
pre-visit planning, microalbuminuria, primary care, diabetes
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Increasing Rates of Urine Albumin Creatinine Ratio Ordering by Providers in Diabetics in
Adult Primary Care: A Quality Improvement Initiative
Introduction
Problem Description
The incidence of diabetes in the United States and across the globe has continued to
climb annually and has reached epidemic proportions. The growth, in part, is fed by the
exponential rise in obesity and weight gain, a leading risk factor for type 2 diabetes (T2DM).
According to the World Health Organization (WHO, 2021), the number of diabetics rose from
108 million in 1980 to a staggering 422 million in 2014, and diabetes was the 9th cause of death
worldwide in 2019. Furthermore, the Centers for Disease Control and Prevention (CDC, 2022)
reports that 37.3 million people in the United States have diabetes, approximately 11.3% of the
population. Diabetes is associated with premature mortality and carries an increased risk of
morbidity from cardiovascular disease, retinopathy, neuropathy, and nephropathy. Diabetic
nephropathy or diabetic kidney disease is present in nearly 1 in 3 Americans with diabetes
(National Institute of Health, 2021). Diabetic nephropathy is defined as the persistent elevation
of urinary albumin excretion (albuminuria), accompanied by a low estimated glomerular
filtration rate (eGFR) in the presence of diabetes (American Diabetes Association, 2022). The
diabetic patient with albuminuria is at a 2 to 4 times increased risk of death from cardiovascular
disease (Patel & Simmons, 2019). Diabetic nephropathy is also the leading cause of end stage
renal disease (ESRD) (McGrath & Edi, 2019), which is treated with kidney transplant or dialysis.
According to the CDC (2017), primary care office visits accounted for approximately
52.3% of all outpatient visits, with diabetes ranking as the 5th most common primary diagnosis
among such visits. Primary care is positioned as the center focus for both screening and
treatment of patients with diabetes, delivering clinical care to approximately 90% of individuals
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with T2DM (Shrivastav et al., 2018). With the vast majority of diabetics being treated in primary
care, it is essential that primary care clinicians remain up to date and follow the latest screening
and treatment guidelines. According to the American Diabetes Association (ADA, 2022),
urinary albumin and eGFR should be assessed in type 1 diabetics with a disease duration greater
or equal to 5 years and in all type 2 diabetic patients on an annual basis.
Upon evaluation of one academic medical center affiliated primary care practice, rates of
screening for diabetic nephrology with urine microalbumin completion in patients with diabetes
were low. As microalbuminuria is the earliest detectable marker of diabetic nephropathy
(McGrath & Edi, 2019), it is essential that primary care clinicians are ordering spot urine
microalbumin creatinine ratio screening tests (uACR) at minimum on an annual basis.
Identification of patients with albuminuria allows for timely treatment and can inhibit disease
progression and ultimately reduce the risk of cardiovascular complications and prevention of
ESRD.
Available Knowledge
The available literature outlines the adverse effects and sequelae of progressive diabetic
nephropathy. Low rates of screening for diabetic nephropathy in diabetes has been consistently
demonstrated in the literature. There are several studies and quality improvement initiatives that
have similarly worked to enhance screening for diabetic nephropathy with uACR testing in
primary care settings. Another outcome examined included provider perception of the
importance of ordering a uACR screening test.
Using retrospective data from the electric health record (EHR) over a 3 year period
between 2016 and 2019, Stempniewicz et al. (2021) examined screening rates of uACR and
eGFR in patients with T2DM across 24 health care organizations and 1,164 clinical practice
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sites. This included a total of 513,165 patients with T2DM, with the diagnosis used in the past 2
years and greater than or equal to one visit with their primary care clinician in the past year.
Among this examined population, just over half (54.2%) had eGFR and uACR tested within the
previous year. Testing rates for uACR varied throughout different locations, from 44.7 to 63.6%
across organizations to numbers as low and high as 13.3 to 73.7% across clinical practice sites.
There were no significant patient demographic differences between those who had testing
completed than those that did not. The prevalence of detected albuminuria was about 15%, and
increased in a linear fashion with uACR testing rates at each specific site. Stempniewicz et al.
(2021) reveals the gap and variability in screening for diabetic nephropathy across primary care
at a variety of healthcare organizations despite ADA guideline recommendations in diabetes.
In a United Kingdom based quality improvement initiative, patients with T2DM were
distributed an information leaflet on the uACR test and assessed three separate outcomes. These
included the number of patients who understood why they were asked to give a urine sample
before and after reading the leaflet, patient satisfaction with the leaflet, and patient’s motivation
to bring in a urine sample after reading the leaflet (Willison et al., 2016). The leaflet was a single
page printed in black and white and was distributed by the phlebotomist along with a cup to
collect urine. In surveyed patients prior to reading the leaflet, 76% of patients did not know that
the urine sample was being obtained to assess for kidney damage. Moreover, after reading the
leaflet, 99% of patients understood the reason for uACR testing and 64% felt motivated to bring
in a urine sample (Willison et al., 2016). Not only does this highlight the lack of knowledge
among patients with T2DM, it underscores the importance of education strategies and the
potential correlation with increased screening rates in educated patients.
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In an upstate New York based primary care practice consisting of six faculty member
primary care providers, patients with T2DM over a two year period were included for uACR
assessment. Patients with CKD stage IV or V or those followed by a nephrologist were excluded.
Anabtawi & Mathew (2013) then conducted a two stage quality improvement initiative, where
EHR generated reminders for overdue screenings were sent to PCPs upon accessing a patients
chart. After two years, of the 232 patients included in the study, uACR screening was ordered in
120 patients (56.3%), with the test being collected in 101 of these patients (84.2%). The results
of screening uACR rates were sent to the PCPs. One year after this intervention, uACR rates of
ordering and completion were reassessed. The sample size was slightly smaller (n=227), and
demonstrated that the test was ordered in 158 patients (69.6%), with 134 of these patients
following through with test completion (84.8%). This demonstrates the effectiveness of
directing provider attention the outstanding test with an integrated electronic chart reminder. It
also highlights the value of data review, bringing awareness to potential missed opportunities to
increase uACR ordering.
A multifaceted resident led quality improvement initiative at a university affiliated
academic family medicine clinic successfully led to improvement in uACR screening. The
project focused on improving compliance with the Medicare Healthcare Effectiveness Data and
Information Set (HEDIS) for attention to nephropathy. The measure gives credit for medical
attention to nephropathy for those patients between 18 and 75 with diabetes who receive an
annual uACR screening, are treated with an ACE inhibitor or ARB in the presence of evidence
of nephropathy, or have a nephrology referral (Curran et al., 2020). The project emphasized
nephropathy screening with a uACR. Prior to the project, an initiative to increase quality
measures led to nurses pending specific orders such as overdue vaccines and hemoglobin A1c
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measurements. Despite this, screening for urine microalbumin remained low. As a result, QI
interventions were deployed which included displaying information for patients and staff in the
laboratory waiting area, distribution of a “cheat sheet” flowchart to providers regarding the
HEDIS metric, as well as adding water to the waiting room. As part of improving the process of
care delivery, an additional step to pre-visit planning with the note of “needs urine, please offer
water” was placed into the reason for the visit. At the project conclusion, 84.3% of eligible
patients successfully met the HEDIS metric, a 5% increase from baseline and the highest
achieved percentage in 2 years. This quality improvement initiative demonstrates a team-based
approach starting with the front office staff offering water to increasing provider’s understanding
regarding the metric, which ultimately improved rates of screening by fulfilling the metric.
A quality initiative that took place in two primary care-based clinics in the Midwestern
United States utilized interventions such as chart auditing with feedback, provider education of
clinical practice guidelines, and strategies from TeamSTEPPS. Within the clinic, all
nonpregnant adult diabetics were included (n=503), excluding 24 due to a nephrology referral,
and 26 because they did not return for a second follow up within 18 months (Hughes-Carter &
Hoebeke, 2016). Post intervention, chart review revealed that the frequency of ordering urine
microalbumin increased from 53.3% (n=148) to 75% (n=148), with an increased rate of
diagnosis of diabetic kidney disease from 3.3% (n=10) to 10.7% (n=21) over a three month
intervention period (Hughes-Carter & Hoebeke, 2016). The significance of these findings
underscores the strength of chart audits and provider education, as well as the potential
underdiagnosis of diabetic kidney disease in the absence of screening.
Rationale
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The literature suggests that provider education, pre-visit planning, patient education, and
provider reminders to reduce missed opportunities are effective tools at improving rates of uACR
ordering and completion. The health effects of diabetic nephropathy are numerous, with
increased cardiac morbidity and mortality and well as the progression to ESRD. Taking into
account the potential for serious healthcare complications associated with CKD, the healthcare
costs are exorbitant, with an estimated 34 billion dollars spent on management of CKD in 2015
(Betts et al., 2021). Prevention of T2DM, understanding risk factors associated with T2DM,
abiding by diabetic nephropathy screening guidelines, treatment strategies, and specialty referral
can prevent the progression of diabetic CKD.
Poorly controlled or undiagnosed diabetes is associated with numerous life altering
complications. According to the WHO’s (2016) Global Report on Diabetes, diabetes was
attributed to 1.5 million deaths in 2012, with 2.2 million additional deaths related to
hyperglycemia complications including cardiovascular diseases, chronic kidney disease, and
tuberculosis (complicated by hyperglycemia). This impact globally, as well as 37 million
Americans affected by CKD, with 1 in 3 having diabetes (NIH, 2020), demands increased
attention and action. The eye-opening impact within the United States and around the World
beckons increased alertness from the primary care providers on the front line of diabetic care.
Perspective is enhanced by the staggeringly low uACR screening rates in diabetics: only 41.8%
among patients on Medicare and 49.0% among patients with private insurance in 2018 (Saran et
al., 2019).
Diabetes is both prevalent and costly, with several process and care outcomes that are
well defined and easily measured. Diabetes is therefore often the focus of quality payment
programs. Healthcare Effectiveness and Data Information Set (HEDIS) developed by the
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National Committee for Quality Assurance (NCQA) is a standardized set of comprehensive
performance measures crafted to supply purchasers and consumers with the information needed
for valid comparison of healthcare performance (CMS, 2021). HEDIS measures relate to many
public health issues, including smoking, cancer screening, diabetes, and heart disease. Likewise,
HEDIS measures are used by more than 90% of health plans in the United States, and contain
multiple metrics for comprehensive diabetes care (AHRQ, 2016). More than 191 million people
are enrolled in plans that report HEDIS measures, which makes it one of health care’s most
widely used performance improvement tools (NCQA, 2021). In 2020, NCQA retired the
Comprehensive Diabetes Care—Medical Attention to Nephropathy metric and developed the
Kidney Health Evaluation for Patients with Diabetes (KED). This metric measures the number
of patients with both type 1 and type 2 diabetes between the ages of 18 to 85 years of age who
received a kidney health evaluation defined by an eGFR and uACR during the measurement year
(NCQA, 2021). Most notably, the upper age limit of screening criteria increased from 75 to 85
from the previous metric. The measure was developed in collaboration with the National Kidney
Foundation (NKF) and as with all HEDIS metrics, will use claims data and search healthcare
payment related information such as Current Procedure Terminology (CPT) codes to ensure the
measure is satisfied. This screening guideline also remains a longstanding recommendation from
the American Diabetes Association is published in the Standards of Medical Care in Diabetes—
2022.
Using a microsystem approach in an internal medicine practice, increased rates of early
detection and screening may decrease escalating diabetic related adverse health effects, and
ultimately reduce the economic burden within the local patient population. Adhering to current
diabetic nephropathy screening practices as recommended by the ADA by ordering and
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collecting a uACR at least annually would satisfy a portion of the of a diabetes related HEDIS
metric. This would not only increase the clinic’s compliance with the metric, but may increase
associated reimbursement which will align to the organization’s financial objectives.
The Plan-Do-Study-Act (PDSA) method was employed to evaluate change throughout
the quality improvement initiative. The intervention was designed to enhance pre-visit planning
and create a workflow to mitigate barriers to successfully address care gaps during a primary
care visit. The PDSA cycle was used to evaluate a reduction in missed opportunities as defined
in the specific aim statement.
Cost Benefit Analysis
The healthcare associated economic burden of chronic kidney disease is enormous. In
2017, Medicare spending for all beneficiaries was in excess of 120 billion, accounting for a
33.8% of total Medicare fee for service spending. Moreover, annual Medicare spending for
individuals with CKD was approximately $16,112, but increased to $19,739 in those with CKD
who also have diabetes (Betts et al., 2021). In a retrospective cohort study using data information
from 2008 to 2017 (n=106,369), patients with T2DM and newly diagnosed CKD incurred an
average cost of $24,029 in the first year following CKD diagnosis (Folkerts et al., 2020).
Furthermore, patients with stage V CKD incurred an annual cost of $110,210, with a 7 fold
increase in risk of inpatient hospitalization than those with stage I CKD (Folkerts et al., 2020).
In another study, Nichols et al. (2020) found that the mean total healthcare costs of patients with
comorbidities associated with CKD were 31% higher than those without comorbidities. Relative
to hospitalization, the associated costs accounted for approximately 35% of CKD attributed cost.
That number increased to 55% in patients with both CKD and heart failure (Nichols et al., 2020).
Another retrospective cohort study of individuals with CDK and T2DM (n=52559) estimated 4-
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month management costs associated with stage I to V (without dialysis) CKD to average $7,725
to $11,879. Those costs increased to $87,538 for those patients on dialysis and $124,271 for
those patients who underwent kidney transplantation (Betts et al., 2021). The expenditure
associated with diabetic related CKD further emphasizes the need to focus on clinic-based
screening to increase the likelihood of early intervention in the primary care setting.
Specific Aims
The global aim of this quality improvement initiative is to reduce the number of missed
opportunities to screen diabetic patients for evidence of nephropathy when a patient has contact
with primary care. As a result of the increased number of screening tests ordered and completed,
patients that screen positive for diabetic nephropathy will be identified and treated. Early
identification of diabetic kidney disease may prevent disease progression, decrease diabetes
related morbidity and mortality, and reduce healthcare costs.
The specific aim of this quality improvement initiative was to increase the number of
ordered uACR screening tests in patients with type 1 and type 2 diabetes between the ages 18
and 75 that have not had a test completed within the past year. This screening guideline aligns
with the American Diabetes Association’s recommendation and mirrors a portion of a diabetes
related HEDIS metric. The goal of this quality improvement project was to avoid missed
opportunities for ordering and signing a uACR order when a patient is present for an office visit,
independent of office visit type. These visit types will include follow up visits, annual physical
exams, new patient visits, hospital follow up visits, office visits, preoperative visits, telehealth
appointments, same day appointments, and annual wellness visits.
Methods
Context
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This quality improvement initiative was conducted in the internal medicine division of a
primary care clinic. The clinic is part of a community group practice affiliated with an academic
medical center. The practice is located in Manchester, New Hampshire, the largest city by
population size in the state. The flagship campus of the medical center is located approximately
1 hour from the practice site. It is the largest employer and the only academic medical center in
the state. The internal medicine group at the site consists of seven physicians (MD, DO), three
nurse practitioners, and two physician assistants. The providers are divided up into four teams:
A, B, C, D. For the purposes of this quality improvement initiative, the focus will be on teams A
and D, who have the highest number of diabetic patients within their respective panels. The
clinic has an imbedded registered nurse who is a certified diabetes education specialist (CDES)
as well as a clinical ambulatory pharmacist who also holds the CDES credential. This team
assists referred patients in regard to specific teaching and education. Services rendered by this
team include education regarding diabetic diet, device management, improved glycemic control
with exercise, medication teaching including education regarding administration of injectable
medications, as well as medication specific recommendations for providers to review. The
primary care providers within these two teams predominantly manage the patients with T2DM
independently. There are a handful who are medically complex, difficult to manage despite
multiple antidiabetic medications, or insulin dependence who are also comanaged with
endocrinology. All patients with T1DM follow with endocrinology.
At present, there is no standardized or formal procedure in place for collecting a uACR in
this internal medicine department. Within the electronic medical record, there is a healthcare
maintenance section that highlights overdue screenings, vaccinations, and other tests
recommended specific to that patient’s medical history and age demographic. In patients with
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diabetes, measures that populate include uACR and serum creatinine (yearly in patients 18 to
75), hemoglobin A1c (every 6 months if <8, every 3 months if > 8), and an annual eye exam. It
is generally within the provider’s workflow to review overdue or upcoming health maintenance
opportunities at every visit. However, there are numerous missed opportunities for orders to be
placed or testing to be obtained.
Appointment blocks for patients presenting for chronic care management visits (including
T2DM management) within the clinic schedule are assigned for 20 minutes. Similarly, 20minute visits account for most other visit types, including same day appointments. Visit types
that encompass the 40-minute time block include hospital discharge follow ups, annual physical
exams, as well as Medicare annual wellness visits. Most patients who are scheduled for a
chronic care follow up present to the lab prior to their visit to have current specified orders
fulfilled. This ensures results are available for providers to review in real time at the upcoming
appointment. This current practice varies slightly between providers and also highly depends on
patients’ compliance and adherence. This clinic has phlebotomy services on site and houses a
full service lab. Primary care also has the ability to perform point of care hemoglobin A1c
testing and also allows for a urine sample to be collected and walked down to the lab by a
medical assistant (MA). This current practice allows for a same day uACR to be obtained and
processed if needed.
Interventions
The approach adopted to improve uACR screening rates focuses on pre-visit planning
and avoiding missed opportunities. The emphasis was placed on the queuing and pending of an
order for a uACR in those diabetic patients flagged as overdue within their electronic chart. The
overdue order will serve as a reminder for the provider who will sign the order where a workflow
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for urine collection and transport to the lab will take place at the conclusion of the visit
encounter.
Prior to the implementation of the intervention, a 20-minute group WebEx meeting was
scheduled for the 8 providers involved in the quality improvement initiative. Due to prior
commitments and vacations, only 5 of the 8 providers were able to attend. The QI project lead
met separately with those who were unable to attend. During the meeting, the project charter and
guidelines for diabetic nephropathy screening were reviewed. A process map was also presented
regarding the proposed order queuing and specimen collection process (Figure 1). The meeting
also provided ample opportunity for the involved providers to ask questions and provide
feedback. Similarly, the QI project lead also met with the MA’s assigned to team A and D
involved with specimen collection. The new process was also reviewed with each individual
MA. Opportunity was provided for them to ask questions and provide feedback regarding the
intervention process. The patient data coordinators charged with pending the overdue uACR
orders were located off site and communication was maintained through electronic mail.
A pre-visit planning intervention was enacted over a 2-month intervention period. At the
beginning of each business day, a report was generated with a list of patients coming in that day
with an overdue uACR. This was limited to patients on internal medicine teams A and D. The
data from the report was then used to queue and pend orders for provider signature, which
appeared when the provider accessed the encounter. Additionally, the pending uACR order was
used to flag the MA rooming the patient of the overdue test and prepare a urine collection
container. The labeled container was then placed on the counter next to the sink in the exam
room. In order to avoid detracting time from scheduled office visits, the provider handed the
patient the cup at the end of the visit and directed them to the bathroom. The pended order was
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signed by the provider during the office visit encounter. As with previous standard procedure, the
MA printed the order, placed it in a specimen bag, and walked the urine specimen to the lab to be
processed and resulted. The process map for the intervention is depicted below in figure 1.
Figure 1
Process Map for uACR Collection.

The clinic employs two patient data coordinators, whose job is to obtain records, send
patient communications in regard to overdue screenings, and update the health records with
outside data. The patient data coordinators generated the daily reports as part of the pre-visit
planning intervention and served in the role of queuing and pending the overdue orders for the
upcoming visit encounters. The orders were pended the day before the upcoming visit. The
uACR was pended independent of patient visit type or chief complaint.
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Having an overdue uACR order queued and pended by a patient data coordinator was
intended to serve as key reminder to the front-line MA and provider to thwart a missed
opportunity for collection. An emphasis on collection and ordering was expected to increase the
compliance rate for uACR provider ordering and consequently increase diabetic nephropathy
screening.
Study of the Interventions
Baseline data extracted from the electronic medical record via an Epic Workbench report
during the previous 2 months leading up to the intervention period served as baseline data. This
same report served as the primary method of data collection. During the 2-month intervention
period, data was extracted on a biweekly basis to evaluate the effectiveness of the intervention.
This author is unaware of other clinic-based quality improvement initiatives or deviation
from standard practice in regard to diabetic nephropathy screening in the 2 months leading up to
the intervention and during the 2-month intervention period. In this setting, confidence can be
placed on the uACR screening improvements during the intervention period correlating with
success of the interventions.
Measures
The measure selected to evaluate outcomes of the intervention was a portion HEDIS
criteria, Comprehensive Diabetes Care—Medical Attention to Nephropathy metric. While this
metric is in the process of being retired and replaced with the Kidney Evaluation Metric, the
medical record and therefore existing workbench report were not configured to capture the
expanded age from 75 to 85. Likewise, the Comprehensive Diabetes Care metric gives credit for
those patients on an angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor
blocker (ARB) for renal protection. One the other hand, the new Kidney Health Evaluation
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metric recommends a uACR be performed regardless of whether a patient is on an ACE or ARB.
This QI project did not include or exclude patients prescribed ACE or ARB medications. In light
of the existing configuration of the electronic medical record and the capture of the report, the
Comprehensive Diabetes Care metric was used to derive the specific outcome measure used. In
consequence, this project intended to gauge the number of patients with both type 1 and type 2
diabetes between the ages of 18 to 75 years with an overdue uACR between August 8, 2022 and
October 7th, 2022. This screening guideline also mirrors recommendations from the American
Diabetes Association is published in the Standards of Medical Care in Diabetes—2022.
The utilized Epic Workbench report extracted data from the medical record that was used
throughout the duration of the QI intervention. The patients included were those with type 1 and
type 2 diabetes with an overdue urine uACR flagged within the health maintenance portion of
the medical record. Furthermore, 2 months of baseline data was extracted prior to the
intervention period. The aim of this quality improvement project was to increase the number of
ordered uACR testing in patients that were overdue in an attempt to reduce the number of missed
opportunities. On a broader scale, the intent is to increase the number of patients screened for
diabetic nephropathy, with the objective to identify and treat patients before the progression of
sequelae related to diabetic nephropathy. The existing report utilized in this quality
improvement initiative captures a wide scope of other performance metrics including
hemoglobin A1C measurement and mammography data. The same report has been used by the
organization for various other quality improvements in the past. Despite the large capture of
data, only data related to uACR was used within this quality improvement project.
This author and/or practice mentor communicated with the patient data coordinators who
were responsible for queuing and pending the uACR orders within the upcoming encounters on a
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biweekly basis. The patient data coordinator kept a manual list of those patients in which
uACRs were pended. This ensured that the uACR orders pended in overdue patients matched
against those that appeared on the biweekly Workbench report. Likewise, 2-3 charts were
audited at random from each biweekly report to ensure the accuracy of the data and as a means
of understanding why a missed opportunity may have occurred. Charts were chosen at random
by the QI project lead and the context of the visit encounter was reviewed. This also provided an
opportunity to validate that an active order was signed as indicated on the report. There were no
patients that appeared on the report that did not match up with the list maintained by the patient
data coordinators.
Analysis
The report was run on a biweekly basis to compare missed opportunities and total number
of orders signed with the combined total of all opportunities. Calculating percent compliance
was done by comparing the total number of signed orders to a denominator of all potential
patient encounter opportunities. Compliance was assessed by individual provider, provider team
and provider type. In addition to looking at individual factors such as provider type, office visit
type was also evaluated. Compliance was assessed for each office visit type and expressed as a
percentage following the same process outlined for individual providers.
It is important to note that variation may exist respective to individual providers during
vacations. This quality improvement project began with a retrospective analysis of
preintervention data. The time period analyzed crossed the summer months, a popular vacation
time for many team members in the clinic. The intervention period also crossed the later end of
the summer vacation period. Likewise, pending the orders the day before the scheduled
encounter did not account for same day visits. While this set up further potential for additional
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missed opportunities, a manual list was maintained by the patient data coordinators. This was
used to ensure that all the patients who appeared on the report correlated with those in which the
uACR orders were pended.
Ethical Considerations
This project was reviewed by the University of New Hampshire Department of Nursing
quality review committee to ensure no internal review board (IRB) approval was needed. This
entity has been granted authority by the University of New Hampshire IRB to ensure this project
was quality improvement based and not research based. Similarly, this quality improvement
project was submitted for approval by the Dartmouth Hitchcock IRB prior to the implementation.
The IRB determined that the quality improvement initiative did not involve human subjects and
that formal IRB review and approval was not required. Organizational policies and procedures
were followed for the duration of this project. All data gathered for use within this project was
deidentified and patient confidentiality was maintained There was no identified risk to patients
in performing this project, as the implementation of pending orders, signing, and collecting them
was no different than current standard patient care. This author has no conflict of interest to
report.
Results
The project timeline is depicted below in figure 2. The intervention was geared toward
reducing missed opportunities for diabetic nephropathy screening. The pre-visit planning
intervention was enacted over a 2 month period where overdue orders for uACR screening were
pended within upcoming visit encounters. The day prior to the visit, the patient data coordinator
queued and pended the overdue uACR order for provider signature. Upon accessing the
encounter on the day of the visit, the pending order flagged the MA to leave a labeled specimen
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cup on the counter for urine collection. The intent was for the provider to sign the pending order
during the visit, hand the patient the specimen collection container, and direct the patient to the
bathroom at the conclusion of the visit.
Modifications to the Intervention
Initially, the goal was to capture missed opportunities for diabetic patients from age 18 to
age 85 as outlined in the updated HEDIS metric. However, the existing report used to gather the
data only captured patients up to age 75, and therefore the outcome measure was updated to
reflect the medical record and report configuration. It should also be reiterated that overdue
uACR screenings were not included or excluded based on ACE/ARB status.
MA staffing proved difficult to ensure the consistency of uACR specimen collection.
Due to staffing shortages, MA’s were floated from other departments and were unaware of the
QI intervention. However, participating providers were aware of the process of the intervention.
If a labeled specimen cup was not placed on the counter for urine collection by the MA, the
providers were aware to dispense a urine collection container at the conclusion of the encounter.
As standard part of the intervention, the provider then instructed the patient to the bathroom and
informed the MA of the specimen for delivery to the lab. It should be clarified however, that
scope of this QI project did not include the measurement of urine specimens collected,
processed, and resulted but rather focused on the number of signed uACR orders.
Contextual Elements
The quality improvement intervention received full support of clinic leadership including
the associate medical director. Leadership blocked time from the QI project lead’s schedule in
order to facilitate biweekly meetings with the practice mentor. The practice mentor is the quality
improvement physician lead for the community group practices. Time was also allowed for the
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project lead and practice mentor to conduct an intervention kick off meeting with clinic
leadership and team members. Approval was granted for the patient data coordinators to
participate in this initiative, whose role went above and beyond typical job responsibilities.
Data Management
Results were released every 2 weeks and formatted into a Microsoft Excel Spreadsheet.
The project lead and the practice mentor met every two weeks for data review. The data was
also submitted to the patient data coordinator to ensure the list of patients in which uACR orders
were pended matched the data released in the biweekly results.
Figure 2
Project Timeline.

Pre Intervention Data
Data was extracted from the medical record using an Epic Workbench report in the 2
months immediately preceding the intervention. Targeting only diabetics overdue for a uACR,
90 patients were seen for clinic visits by providers on internal medicine teams A and D between
June 13th and August 5th, 2022. Of the 90 patients that were overdue, 62 of those patients had an
order for a uACR signed in the visit encounter. During this time period, there were 28 missed
opportunities for this screening test to be ordered, yielding an order compliance rate of 68.9%.
The preintervention order compliance rate by provider is listed below in Table 1.
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Table 1
Pre Intervention Ordering Compliance by Provider.
Provider
Provider 1
Provider 2
Provider 3
Provider 4
Provider 5
Provider 6
Provider 7
Provider 8
Total

Team
A
A
A
A
D
D
D
D

Provider Type

No order Order
Placed
Placed
Nurse Practitioner
2
11
Physician
1
2
Physician
2
8
Physician
4
16
Nurse Practitioner
2
4
Physician
3
8
Physician
6
10
Physician Assistant
8
3
28
62

Total
13
3
10
20
6
11
18
9
90

%
Compliance
84.6%
66.7%
80.0%
80.0%
66.7%
72.7%
55.6%
33.3%
68.9%

Note. This table demonstrates % compliance with uACR ordering in the 2 months immediately
preceding the intervention.
Post Intervention Data
Data throughout the intervention was extracted using the same Epic Workbench report
every 2 weeks throughout the 2-month intervention period between August 8th and October 7th,
2022. Of the 91 diabetic patients seen by Internal Medicine providers on teams A and D, 87
patients had an order for a uACR signed during the visit encounter. This demonstrates an order
compliance rate of 95.6%, with 4 missed opportunities identified. The post intervention
compliance rate by provider is listed in Table 2.
Table 2
Post Intervention Ordering Compliance by Provider.
Provider
Provider 1
Provider 2
Provider 3
Provider 4
Provider 5
Provider 6
Provider 7

Team
A
A
A
A
D
D
D

Provider Type
Nurse Practitioner
Physician
Physician
Physician
Nurse Practitioner
Physician
Physician

No order Order
Placed
Placed
0
12
0
17
0
6
1
13
1
6
0
17
0
11

Total
12
17
6
14
7
17
11

%
Compliance
100.0%
100.0%
100.0%
92.9%
85.7%
100.0%
100.0%
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Physician Assistant

2
4

5
87

7
91

71.4%
95.6%

Note. This table demonstrates % compliance with uACR ordering in the 2 months during the
intervention period.
Comparison
There was an improvement in the number of missed opportunities during the intervention
period. As depicted in Figure 3, the number of signed uACR orders during the intervention
period was consistently high. During the preintervention period, there was considerable
variability in the number of uACR orders signed each week, with ordering compliance as low as
50% during the week of July 4th, 2022. Post intervention, the compliance with ordering a uACR
improved by 26.7 percentage points when compared to the to the preintervention data.
Figure 3
Urine Microalbumin Order Compliance by Week
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Note. This graph demonstrates compliance with uACR ordering by week among providers
cumulatively.
Variability by Provider
There were differences in uACR ordering practice preintervention and throughout the
intervention period. Provider 8 had the highest number of missed opportunities prior to the
intervention with a total of 8 times an overdue uACR order was not placed. Similarly, provider 8
also has the highest number of missed opportunities during the intervention, not signing a pended
uACR order a total of 2 times. In the preintervention period, there were no providers that
ordered an overdue uACR 100% of the time, but provider 2 only missed an order 1 time. During
the intervention period, providers 1, 2. 3, 6, and 7 signed pending orders 100% of the time as
demonstrated below in figure 4.
Figure 4
Missed Opportunities by Provider
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Note. This graph demonstrates missed opportunities by provider before and during the
intervention period.
Variability by Office Visit Type
The majority of the encounters in which patients were overdue for uACR orders were
follow up visits. Of the 181 total visits preintervention and during the intervention, 114 of those
were follow up visits. In the 2-month period preintervention, there was a 74.6% uACR order
compliance for follow up visits. However, postintervention, there was an improvement with the
rate increasing to 98.2%, an improvement of 23.6 percentage points. Additionally, there was a
improvement in percentage of missed opportunities reflected in the same day visit type.
Preintervention, the order compliance rate was 14.3%. This increased to 90% post intervention,
an improvement of 75.7 percentage points as demonstrated below in Figure 5. Annual wellness
visit, hospital follow up visit, and annual physical exam order compliance was consistently high
in the preintervention period, but demonstrated 100% compliance post intervention. Visit types
including office visit, new patient visit, and telehealth visit made up only a small percentage of
throughout the intervention period. There were no preop visit types throughout the intervention.
Office visit type pre and post intervention are quantified in Appendix A.
Figure 5.
Order Compliance Pre and Post Intervention by Office Visit Type.
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Discussion
Summary
This quality improvement initiative underscored the importance of avoiding missed
opportunities and taking advantage of all patient contact to perform diabetes follow up as a team.
The stark difference in the number of signed uACR orders brings to light the potential
advantages of a pre charting intervention to avoid missing vital recommended screening tests.
Key Findings
In the two months leading up to the intervention, the number of missed opportunities for
diabetic nephropathy screening was high. The data collection process pre and post intervention
were mirrored. By the conclusion of the intervention period, there was an order compliance rate
of 95.6%. This exceeds the previous order compliance rate of 68.9% in the preintervention
period, an improvement by 26.7 percentage points. The findings of this initiative correlate with

INCREASING RATES OF URINE ALBUMIN

30

the specific aim of improving the number of ordered spot uACR tests in adult patients between
the ages of 18 and 75. However, it is unclear whether the intervention upheld the global aim of
improving the rate of screening, as the number of collected and processed uACR tests was not
measured. The goal was to increase compliance of uACR ordering whenever a patient was due
regardless of office visit type. The success of this goal is reflected in the order compliance
percentage by office visit type, with improvement across all office visit types.
All 8 providers participating in this quality improvement initiative demonstrated an
increase in the number of uACR orders signed. Provider 8 appeared to have the most room for
improvement pre intervention and during the intervention period. During the pre-intervention
period, a total of 8 patients were seen where a uACR order was not placed. Similarly, provider 8
had 2 missed opportunities for order signature during the intervention period, though
significantly improved from the pre-intervention period. Providers 4 and 5 had a single missed
opportunity during the intervention. This further validates the overall increase in order
compliance and confutes any specific provider as an outlier to the improvement.
Additionally, the results report provided details regarding the patients next follow up
appointment. Though not a measured outcome in this project, there was an unexpected finding
regarding the lack of future patient follow up. Throughout the intervention period, out of a total
of 91 patients, 15 patients did not have any further follow up in primary care scheduled at check
out. This accounts of 16.5% of patients seen not being scheduled for further diabetes follow up,
which translates into future missed opportunities for preventative care. Of the 4 patients during
the intervention without a uACR order signed, 2 of those patients did not have any follow up
scheduled in primary care. This calls to attention the importance of taking advantage of
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addressing diabetes and overdue screening at every office visit, independent of the booked
reason for the visit.
While global aim of this quality improvement initiative focused on thwarting diabetic
kidney disease and decreasing healthcare costs, these factors were not specific aims and therefore
were not measured or captured within the results. However, increased rates of ordered uACR
screening tests is the first step in avoiding the sequalae of uncontrolled diabetes.
Strengths
The most celebrated strength of this quality improvement initiative is the success of
achieving an increased number screening uACR tests ordered. The increased number of orders
placed with a streamlined process for uACR collection provided the proper conditions for
improved uACR order rate. Resulted tests provide opportunity to intervene early if diabetic
nephropathy is discovered. It is a longstanding guideline to screen diabetic patients on a yearly
basis for nephropathy in the primary care setting. However, the number of tasks bestowed upon
primary care providers within short appointment windows introduces failure to address important
preventative care. Utilizing support staff to streamline completion of health maintenance
measures reduces strain on providers. Arranging a pre-visit planning process for orders
placement serves as a clear reminder to the provider that the patient is overdue a screening test.
It also supplies the provider the ease of signing the order with a single click.
Additionally, the use of team members from different disciplines fostered partnership and
collegiality. This was an unintended consequence, but the improved communication between
MA’s and providers should be noted. It also cultivated inclusivity by welcoming the patient data
coordinators to the team as ability to interact with clinic staff is limited by the typical nature of
their work and offsite location.
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Interpretation
The intended outcome of this quality improvement initiative was to increase the number
of screening uACRs ordered as defined by a portion of the HEDIS metric. More specifically
those patients with type 1 and type 2 diabetes who had not completed a screening uACR within
the previous year. The age range was capped to age 75 as outlined in the retired Comprehensive
Diabetes Care—Medical Attention to Nephropathy metric rather than expanded to age 85 per the
updated Kidney Health Evaluation metric. The reason for this is discussed further within the
limitations section below. The intervention aimed to reduce missed opportunities by pending
uACR orders into upcoming visit encounters for providers to sign was a success. As the order
appeared for signature upon opening accessing the encounter, it immediately alerted the provider
of the overdue screening metric, prompting signature and the subsequent collection process.
Consequently, it became difficult to overlook the overdue screening test and highlighted the need
to address it, even if the visit was not intended to address diabetes. As a result, 87 out of 91
orders were successfully signed during the 2-month intervention period, a collection rate of
95.6%.
Relation to Other Evidence
Among existing publications that aimed to improve diabetic nephropathy screening,
interventions were targeted toward increasing provider order rates but also order completion.
For instance, Anabtawi & Mathew (2013) conducted a two stage quality improvement initiative
that not only examined provider order rates, but follow up was performed to see if the orders
were completed. The intervention focused on EHR triggered reminders for providers but there
was no process or intervention that focused on improving urine collection. However, more
orders were successfully placed as a result of the EHR generated reminder, improving from an

INCREASING RATES OF URINE ALBUMIN

33

order rate of 56.3% to 69.6% after the intervention began (Anabtawi & Mathew, 2013). Rates of
urine completion for said orders placed remained virtually unchanged at 84.2% and 84.8%
before and after the intervention respectively. The results published in Anabtawi & Mathew
(2013) reflected a substantially lower provider order rate than was seen in this quality
improvement initiative. An EHR reminder alone without a process improvement strategy was
inherently less effective and this is reflected within the results.
Additionally, Curran et al. (2020) also used the HEDIS Medical Attention to
Nephropathy metric as a primary outcome measure. A multifaceted intervention took place
including displaying information for patients and staff in the laboratory waiting area, distribution
of a “cheat sheet” flowchart to providers regarding the HEDIS metric, as well as adding water to
the waiting room. Additionally, as part of the pre-visit planning intervention, a comment was
added to a patient’s reason for visit, indicating that a uACR was overdue and to offer water at
check in. By the completion of the intervention, eligible patients fulfilling the HEDIS metric
improved by 5 percentage points (Curran et al, 2020). The outcome specifically examined
patients that successfully fulfilled the HEDIS metric with the above set of interventions. This
differed from this improvement project, as only a portion of the HEDIS metric was used to
define the specific aim. Likewise, the number of orders placed was measured, rather than the
number completed orders. It is not possible to compare percentage improvement in fulfilling the
HEDIS metric and order compliance rate as they are different outcome measures. The
opportunity to use the complete HEDIS metric as an outcome measures opens the door for future
PDSA cycles.
Lastly, Hughes-Carter & Hoebeke (2016) used an intervention targeting provider
education regarding clinical practice guidelines. While the rate of ordering with subsequent
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completion of the order successfully increased from 50.3% to 75% in 3 months, it is
exceptionally lower than the rate of 96.4% achieved during this quality improvement initiative.
However, order completion was not measured as part of this quality improvement initiative.
Impact on People and Systems
Members of this quality improvement initiative included patient data coordinators,
medical assistants and primary care providers. The completion of health maintenance measures
such as ordering screening tests and vaccinating patients comprises the foundation of primary
care. As such, the ordering of a uACR screening test is within the purview of routine primary
care practice. Providers order this test on a regular basis, but are required to take the extra step of
examining the overdue care gaps and taking the initiative to place the overdue orders. However,
based on preintervention data, there was opportunity to enhance the compliance with addressing
uACR screening. The intervention therefore has little impact on provider practice, other than
increasing the number of order results from collected uACR samples. Similarly, collecting urine
samples is part of typical practice for an MA. This practice has been established due to the
volume of patients who present with a symptomatic urinary complaint. The difference within
this intervention involves the placement of a labeled specimen container in the exam room for
the provider to hand to the patient at the termination of the visit. This process does not take any
additional time and does not detract time away from the provider visit, as the urine is not
collected until the encounter has been completed. Lastly, the daily report and the pending of the
uACR order tasked among the patient data coordinators is an extra step that is among their
typical practice. This calls into question the concept of sustainability beyond the confines of the
intervention period.
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Ideally, patients who are scheduled for visits would be seen by their own PCP or within
their respective team. Due to limited availability of appointments with associated high demand,
this is not always possible. In the cases patients screen positive for diabetic nephropathy with an
unacquainted provider, it may burden the provider to address the result, in the absence of an
established relationship or any future follow up. For instance, provider 1 may see provider 2’s
patient for a non-diabetic related visit such as influenza, have a uACR order pended/signed on
the overdue patient, and be tasked with following up on the result despite the fact they did not
address the patient’s diabetes in the office visit. This may thwart providers from engaging in
ordering tests outside of their own patient panel or team which may inhibit the expansion of this
type of intervention or its continuance long term.
On the other hand, this quality improvement project has underscored the value of
screening for diabetic nephropathy and has reinforced positive habits for providers to
consistently address overdue screening. In consequence, providers may be more aware to check
whether diabetic nephropathy screening is overdue and collect the urine sample during future
visits, even after the intervention has ended. It may also call to attention other health
maintenance measures such as colonoscopy or mammography, and further fortifies a routine for
avoiding missed opportunities, despite the chief complaint or type of office visit.
Differences in Outcome
There was a positive association in relation to the outcome measured and the results
achieved. The aim of this quality improvement initiative was to improve screening for diabetic
nephropathy by increasing the number of ordered uACR screening tests in adult type 2 diabetes
between the ages 18 and 75. Based on the specific aim of the QI project, and the results
discussed above, there was a clear increase in the number of ordered uACR screening tests in
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this population. This was the expected outcome based on the design of this initiative.
Throughout the literature there is variation in the structure and design of specific quality
improvement initiatives relative to uACR screening and chronic kidney disease prevention. This
study did not capture the percentage of ordered uACR that were successfully collected and
processed by the lab. Future iterations of this work might include expanding variables under
this consideration to ensure ordered uACR and collected uACR are captured. This will allow for
further enhancement of the project and patient outcomes.
Cost
The costs associated with this quality improvement project were minimal. The
organization did not incur any costs associated with educating MA’s and providers as the DNP
project lead was employed by the organization, and regular meeting time was used to provide
education. While there may have been an increase in specimen cup utilization, the collection of
a yearly uACR was existing standard practice at the organization. Specific costs incurred with
the increased use of specimen cups was not measured. In addition, there was a potential
opportunity cost associated with the hyperfocus on this quality metric. Time dedicated toward
diabetic nephropathy screening may have detracted time from several other screenings that are
performed in the primary care setting such as smoking cessation or depression screening. As
such, the amount of time allotted to each appointment and the rooming process did not increase.
If the MA rooming patients was distracted by the uACR process change, it may have altered
their workflow and caused lapses in other measures. This should be considered as this project
enters the sustainability phase.
Limitations

INCREASING RATES OF URINE ALBUMIN

37

Several limitations should be recognized within this quality improvement initiative. The
specific aim was to increase the number of ordered microalbumin creatine ratio tests in adult
type 2 diabetes between the ages 18 and 75 over a 2 month period. Initially, the age was
intended to reflect the Kidney Health Evaluation update to the HEDIS criteria, which expanded
the screening age to age 85. Due to the configuration of the organization’s electronic medical
record still only defining overdue patients up to age 75, capturing the expanded age was not
possible amid time constraints and the construction of existing reports. The decision was
therefore made to keep the narrower age recommendation of 18 to 75 reflected in the retired
Comprehensive Diabetes Care—Medical Attention to Nephropathy HEDIS metric.
This quality improvement initiative led to an increase in the number of uACR orders
signed. This was directly related to the new process put in place to collect the urine specimen
while the patient was in the office. However, one of the most obvious limitations was that no
follow up was performed to ensure the urine was collected and processed by the lab. While a
signed order is the first step toward completion of the test, patient specific factors such as test
refusal or inability to urinate may have limited uACR collection. There was no additional report
utilized or chart investigation performed to ensure orders were followed through, and therefore
no data is available in regard to that measure. Likewise, the intervention did not take into
account patients being seen with telehealth who were not physically present in the office. While
telehealth visits only accounted for 4 of the 91 visits conducted through the intervention, there
was no plan or process in place for how the uACR was to be collected.
As rate of completed and resulted uACRs was not measured, additional barriers to
completion were not considered. For example, if a patient was not able to produce a sample at
the time of the visit, a process would need to be in place to provide guidance on how to obtain
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the necessary specimen and how to act on the current, active order. When the uACR was pended
by the patient data coordinator, the order requires ‘clinic collect’ or ‘lab collect’ to be selected.
In aligning with the intervention, ‘clinic collect’ was selected. However, in the case a patient
could not urinate after the order was signed, the order would need to be modified to ‘lab collect’
for the lab to appropriately collect and process the sample at a later date or time. This would
require order discontinuation and reorder by the provider. There was no specific process in place
as to how to proceed in those instances, and therefore an invalid clinic collect order may thwart
the lab from collecting the future order.
Variation in staffing was a challenge throughout the quality improvement project.
During the 2 months intervention period, there were 2 MA’s that resigned from their positions.
This added to the existing vacancy on the team with the 2 additional MA positions open. In
order to provide general operational support, MAs from other teams or departments were utilized
for providers on team A and D. Since these MAs were not part of the core team and thus not
educated on the intervention, this added an additional variable. All providers on team A and D
involved in the initiative were aware of the intervention. Consequently, if a labeled specimen
cup as not placed on the counter in an exam room, the provider was able to dispense the cup after
the order was signed at the conclusion of the visit. This was confirmed verbally among 4 of the
providers participating, but this was not formally measured. Additionally, there were 3 provider
vacations during the intervention period and other unexpected absences. This may have
decreased the number of diabetics seen during the intervention period. Another staffing
limitation which may limit the generalizability to other clinics is the lack of a patient data
coordinator resource. While orders could be queued and pended by another team member, the
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consistency of having two dedicated, reliable team members with excellent attendance and
engagement in quality improvement work was a paramount resource to this project.
Efforts for Limitation Adjustment
Throughout the intervention, the patient data coordinators kept a list patients who had a
uACR pended. This was then compared to the biweekly results report. The practice of pending
the uACR orders the day before the appointment does open the door to additional missed
opportunities. For instance, if a patient with an overdue uACR was booked same day, it would
miss the window for the patient data coordinator to pend the uACR order. As with practice prior
to this quality improvement initiative, it would be up to the provider to recognize the overdue
order. However, there were no cases of this happening throughout this intervention, but it should
be recognized as a limiting factor for the future.
Conclusions
The success of the intervention summoned attention to ensuring patients are screened
yearly for diabetic nephropathy. It also called to awareness the importance of reducing missed
health maintenance opportunities and the ability to leverage the multidisciplinary team to provide
excellent patient care. Any patient contact within primary care should serve as a forum for
preserving the health of patients. While it is easy to simply address a patient’s orthopedic
complaint during a same day visit, having a pended uACR order in that encounter acted as a key
reminder of overdue screening when it may not have been otherwise addressed. The small
explanation alongside handing the patient a specimen container only takes an additional minute
or less, but may help avert the devasting effects of chronic kidney disease.
While this quality improvement initiative was productive among improving uACR order
rates, it begs the question of whether the intervention is sustainable long term among the current
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team member complement. The success of having orders pended as part of the pre-visit planning
intervention was highly contingent on having the patient data coordinators as part of the quality
improvement team. The patient data coordinators have been involved in other quality
improvement projects in the past, but the main focus of the role is updating the medical records
appropriately with outside information and sending reminders to patients. Patient data
coordinators already possessed the necessary skill set to participate in this work, making them an
integral part of the process. However, other duties within their job may prevent long term
involvement in the role of pending orders for signature. At the local level, it is within the MA’s
scope of practice to participate in pre-visit planning. If time was allotted and education was
performed, an MA should be able to assume this role.
There are several practice considerations that arose from the results of this quality
improvement initiative. Namely, the question of why the order rate of screening uACRs was low
prior to the intervention and the potential methods to elude future missed opportunities of
ordering screening tests. The high number of tasks that petitions a primary care provider’s
attention within a 20-minute appointment window will continue to be a barrier. As above,
increased involvement of support staff as part of pre-visit planning may detract burden from
providers. Utilizing MA’s may be a viable option in future iterations of this work, however, it is
important to consider attrition as a potential limiting factor.
Furthermore, it beseeches the question of whether lengthening provider visits may
provide more opportunity for providers to deliver a higher level of care. On a similar note,
rewarding providers monetarily based on performance among quality metrics tied to
reimbursement may reduce missed opportunities. While physician compensation structure
accounts for these measures, the advanced practice providers that also carry patient panels are
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not rewarded for their panel specific quality measures. Aside from rewarding providers,
increasing awareness through the distribution of baseline quality metrics specific to each
provider may be another more cost-effective way to increase awareness and keep providers
engaged. Moreover, the lack of follow up appointments booked at check-out conjures the
question of how additional focus on the check-out process may further reduce missed
opportunities. As diabetics patients are generally seen every 3 to 6 months, if no follow up
appointment is booked at checkout, they may be lost to follow up. This concept solicits further
quality improvement work in this space.
The pre-visit planning portion of the intervention where the uACR order was pended may
be useful among the whole complement of health maintenance measures. For instance, a patient
chart is accessed prior to the visit taking place, all overdue orders can be pended, such as
colonoscopy, vaccines, cholesterol screening, and others. In the case that a patient declines a
screening exam, the order can be deleted prior to signature. Not only would this save time for
the provider, but it would serve as a key reminder to address the overdue measure. Additionally,
the pre-visit planning work has the ability to spread outside of team A and D in internal
medicine, but can be translatable to other teams within the practice and across other primary care
divisions within the organization.
The success of the intervention implies the need for further investigation into completion
of overdue screening tests, outside the realm of the provider signing the order. If a signed order
is not acted upon, it is not applicable to an increase rate of screening or treatment for those
diabetic patients with nephropathy. In this light, further follow up needs to be performed in
regard to the urine collection process and what percentage of samples were processed. Further
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work should be done to estimate how many of those patients have established nephropathy and
how many new diagnoses were made as a result of the intervention.
Next Steps
The next steps for continuation to ensure consistent order compliance among providers
within the pre-visit planning scope is to train the MA’s to pre chart. Not only would this take
away the need to run a report daily, but the MA could take the time to review overdue measures
and pend them within the encounter prior to the visit taking place. For the handoff from the
patient data coordinator to the MA to be successful, there would need to be a full complement of
MAs on staff. Similarly, training for MAs across the primary care division would need to be
standardized to include pre-visit planning on a macrosystem level. This would ensure
consistency among all MAs, even if floating between primary care departments was required due
to staffing needs.
Ensuring that diabetic patients are well cared for remains the pragmatic goal of the
primary care providers and health systems. Accordingly, diabetes remains a chronic disease that
commands continuous quality improvement work. Guaranteeing a well-resourced team with
ample time and validated processes in place will ensure patients with diabetes are well cared in
the future.
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Appendixes
Appendix A: Number of Office Visits by Type Pre and Post Intervention
Visit Type

Preintervention

Postintervention

Number of Visits

Number of Visits

Total

ANNUAL WELLNESS VISIT

1

3

4

FOLLOW UP VISIT

59

55

114

HOSPITAL CHECK

4

5

9

TELEHEALTH VISIT

1

4

5

NEW PATIENT VISIT

4

1

5

OFFICE VISIT

1

2

3

PHYSICAL EXAM

12

11

23

PREOP VISIT

1

0

1

SAME DAY

7

10

17

Total

90

91

181

